Uncategorized

Gender parity in tech transfer

By Kristen on June 19, 2018

The theme of International Women’s Day this past March may have been “gender parity,” but at the rate things are going, women won’t file as many patents as men in a single calendar year until nearly 2100, according to the Institute for Women’s Policy Research. But thanks to research from Washington University in St. Louis, published June 18 in T...

Defect in debilitating neurodegenerative disease reversed in mouse nerves

By Kristen on May 1, 2018

Source: the Source – April 19, 2018 Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet and legs. The researchers used the compound to treat the nerves of mice harboring th...

International Women’s Day: Toward gender parity in tech transfer

By Kristen on March 8, 2018

Source: FUSE – March 8, 2018 Tech transfer has had an immense, positive effect on our nation in terms of growth, economic impact and societal benefit. In 2012 alone, more than $38 billion of net revenue was generated by university technology in the marketplace, according to the Association of University Technology Managers (AUTM). But thes...

Q BioMed Inc., Washington University partner to optimize glaucoma diagnostics

By Kristen on March 7, 2018

Source: FUSE – March 7, 2018 Q BioMed, Inc., a New York-based biomedical acceleration and development company, recently announced an exclusive option agreement with Washington University in St. Louis to improve glaucoma diagnostic technology. The agreement was executed through WashU’s Office of Technology Management (OTM) based on IP devel...

CRISPR enhances cancer immunotherapy

By Kristen on March 7, 2018

Source: the Source – March 5, 2018 Last year, the Food and Drug Administration approved the first cellular immunotherapies to treat cancer. These therapies involve collecting a patient’s own immune cells — called T cells — and supercharging them to home in on and attack specific blood cancers, such as hard-to-treat acute lymphoblastic leuk...

LEAP Challenge gets boost from SPARC

By Kristen on March 5, 2018

Source: FUSE – February 16, 2018 A collaboration between Washington University in St. Louis and Sun Pharma Advanced Research Co. (SPARC) will support innovation in drug development and delivery. The Skandalaris Center’s LEAP (Leadership in Entrepreneurial Acceleration Program) Inventor Challenge is getting a boost from Sun Pharma Advanced ...

Q Biomed Inc. Signs Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma

By Tom on February 8, 2018

Source: Yahoo! Finance – February 8, 2018 Q BioMed Inc. (QBIO), is pleased to announce an exclusive option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q BioMed will evaluate the feasibility and usability of GDF-15, a novel biomarker for monitoring glaucoma, ...

Light-triggered nanoparticles show promise against metastatic cancer

By Tom on January 30, 2018

Source: Washington University – January 24, 2018 A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy — which is limited to the skin and areas accessible with an endoscope — this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washing...

Cancer weapon

By Tom on January 10, 2018

Source: Outlook Magazine – January 10, 2018 While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from Washington University School of Medicine and the University of California San Diego School of Medicine shows ...